A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION

Cover Page

Cite item

Abstract

Parvovirus B19 (PV B19) replicates predominantly in progenitor cells of human erythrocytes and is transmitted by an airborne, vertical through and through blood or infected tissues. At-risk are pregnant women, people with immunodeficiency of different nature and individuals who need blood transfusions or organ transplantation. The available data indicate a high risk of infection through transfusion of blood containing the DNA of parvovirus B19, with viral load 105 copies/ml and above (Hourfar M.K. et al., 2011). According to the requirements of national regulations, the production of therapeutic drugs from plasma assumes the use of raw materials, free from viruses or with minimal viral load (Filatova E.C. et al., 2011). In some foreign countries a study of donor blood for the presence of DNA PV B19 is required; in our country the need for such screening is discussed (Giburt E.B. et al., 2013). Due to the fact that parvovirus is resistant to the methods of blood products desinfection, it is especially important to assess the quality of donor blood. Objective: To investigate the prevalence of the two markers parvovirus infection (IgG and PV B19 DNA) in blood samples from one of the blood centers at St. Petersburg. Plasma samples from 100 blood donors from Military Medical Academy blood centre were tested by ELISA for the presence of IgG antibodies of parvovirus B19. Positive samples were tested by PCR for the DNA of parvovirus B19. ELISA test system recomWell Parvovirus B19 IgG (Microgen GmbH, Germany) and diagnostic kits of Federal State Institution of Science «Central research Institute for epidemiology» of Rospotrebnadzor (Moscow, Russia) which are approved for use in RF was used according to the manufacturers instructions. It was shown that 78 out of 100 donors aged 18 to 58 years had IgG-antibodies.76 positive blood plasma samples were investigated by PCR, with the 19 donors have found DNA of parvovirus B19 (25%). Viral load of one donor was 106 copies/ml. In this case, there is the high risk of infection for the recipient. Results obtained are consistent with literature data. Obviously, it is need to investigate donor blood for parvovirus B19 presence. Obvious that quantification of the DNA of parvovirus B19 in blood products is need.

About the authors

Anastassia Ya. Antipova

St. Petersburg Pasteur Institute

Author for correspondence.
Email: anti130403@mail.ru
PhD (Biology), Researcher, Laboratory of Childhood Virus Infection, 197101, Russian Federation, St. Petersburg, Mira str., 14 Russian Federation

O. N. Nikishov

Federal State Military Educational Institution of Additional Professional Education Military Medical Academy named after S.M. Kirov

Email: fake@neicon.ru
Lecturer, Department of General and Military Epidemiology, St. Petersburg Russian Federation

I. V. Khamitova

St. Petersburg Pasteur Institute

Email: fake@neicon.ru
Head of the Central Сlinic Diagnostic Laboratory, 97101, Russian Federation, St. Petersburg, Mira str., 14 Russian Federation

A. V. Semenov

St. Petersburg Pasteur Institute

Email: fake@neicon.ru
PhD (Biology), Head of the Laboratory of HIV Immunology and Virology, 197101, Russian Federation, St. Petersburg, Mira str., 14 Russian Federation

M. A. Bichurina

St. Petersburg Pasteur Institute

Email: fake@neicon.ru
PhD, MD (Medicine), Head of the Virology Laboratory by Elimination Measles and Rubella,197101, Russian Federation, St. Petersburg, Mira str., 14 Russian Federation

A. A. Kuzin

Federal State Military Educational Institution of Additional Professional Education Military Medical Academy named after S.M. Kirov

Email: fake@neicon.ru
PhD, MD (Medicine), Associate Professor, Department of General and Military Epidemiology, St. Petersburg Russian Federation

I. N. Lavrentieva

St. Petersburg Pasteur Institute

Email: fake@neicon.ru

PhD, MD (Medicine), Head of the Laboratory of Childhood Virus Infection, 197101, Russian Federation, St. Petersburg, Mira str., 14

Russian Federation

References

  1. Антипова А.Ю., Лаврентьева И.Н., Бичурина М.А., Лялина Л.В., Кутуева Ф.Р. Распространение парвовирусной инфекции в Северо-Западном федеральном округе России // Журнал инфектологии. 2011. Т. 3, № 4. С. 44–48. [Antipova A.Y., Lavrent’eva I.N., Bichurinа M.A., Lialina L.V., Kutueva F.R. The Spread of parvovirus infection in the NorthWest Federal district of Russia. Zhurnal infektologii = Journal of Infectology, 2011, vol. 3, no. 4, pp. 44–48. (In Russ.)]
  2. Ермолович М.А., Климович Н.В., Матвеев В.А., Самойлович Е.О., Романова О.Н., Черновецкий М.А. Сравнительные эпидемиологические аспекты парвовирусной инфекции В19 у больных с острыми экзантемными заболеваниями и гематологической патологией // Медицинский журнал. 2011. № 3. С. 61–65. [Yermolovich M.A., Klimovich N.V., Matveev V.A., Samoilovich E.O., Romanova O.N., Chernovetskiy M.A. Comparative epidemiological aspects of parvovirus B19 infection in patients with acute asanteni diseases and hematological pathology. Meditsinskii zhurnal = Medical Journal, 2011, no. 3, pp. 61–65. (In Russ.)]
  3. Жибурт Е.Б., Баранова О.В., Рейзман П.В., Кузьмин Н.С. Новое в трансфузиологии (на XXVIII Конгрессе Международного общества переливания крови). Режим доступа: http://www.transfusion.ru/doc/2004-09-03-1.html. Дата обращения: 25.02.2015 [Giburt E.B., Baranov O.V., Reisman P.V., Kuzmin N.S. Novoe v transfuziologii (na XXVIII Kongresse Mezhdunarodnogo obshchestva perelivaniya krovi) [New in Transfusiology (XXVIII Congress of the International society of blood transfusion). Available at: http://www.transfusion.ru/doc/2004-09-03-1.html]
  4. Об утверждении технического регламента о требованиях безопасности крови, ее продуктов, кровезамещающих растворов и технических средств, используемых в трансфузионно-инфузионной терапии (с изменениями от 12 октября 2010 г.): Постановление Правительства РФ от 26 января 2010 г. № 29 (ред. от 04.09.2010) // Собрание законодательства Российской Федерации. 2010, № 5, ст. 536. 31 с. [Ob utverzhdenii tekhnicheskogo reglamenta o trebovaniyakh bezopasnosti krovi, ee produktov, krovezameshchayushchikh rastvorov i tekhnicheskikh sredstv, ispol’zuemykh v transfuzionno-infuzionnoi terapii (s izmeneniyami ot 12 oktyabrya 2010 g.): Postanovlenie Pravitel’stva RF ot 26 yanvarya 2010 g. № 29 (red. ot 04.09.2010) [On approval of technical regulation on the safety requirements of blood products, blood and technical solutions tools used in transfusion-infusion therapy (with amendments as of October 12, 2010): the RF Government Decree of 26 January 2010, no. 29 (as amended on 04.09.2010)]. Sobranie zakonodatel’stva Rossiiskoi Federatsii = Collected Legislation of the Russian Federation, 2010, no. 5, p. 536). 31 p.]
  5. Судариков А.Б., Глинщикова О.А., Макарик Т.В., Февралева И.С. Мультиплексная диагностика вирусов гепатитов В, С и парвовируса В19 у больных, получающих множественные гемотрансфузии // Гематология и трансфузиология. 2008. № 4. С. 54–56. [Sudarikov A.B., Glinschikova O.A., Makarik T.V., Fevraleva I.S. Multiplex diagnostics of viral hepatitis, and parvovirus B19 in patients receiving multiple transfusion. Gematologiya i transfuziologiya = The Hematology and Transfusiology, 2008, no. 4, pp. 54–56. (In Russ.)]
  6. Элижбаева М.А., Февралева И.С., Глинщикова О.А., Сильвейстрова О.Ю., Шипулина О.Ю., Домонова Э.А., Сафонова А.П., Овчинникова Е.Н., Татаева З.М., Судариков А.Б. Выявление парвовируса B19 в крови российских доноров // Гематология и трансфузиология. 2011. Т. 56, № 2. С. 10–13. [Alizhbaeva M.A., Fevraleva I.S., Glinschikova O.A., Silveystrova O.Yu., Shipulina O.Yu., Domonova E.A., Saphonova A.P., Ovchinnikova E.N., Tataeva Z.M., Sudarikov A.B. Detection of parvovirus B19 in blood Russian donors. Gematologiya i transfuziologiya = The Hematology and Transfusiology, 2011, vol. 56, no. 2, pp. 10–13. (In Russ.)]
  7. Chisaka H., Ito K., Niikura H., Sugawara J., Takano T., Murakami T., Terada Y., Okamura K., Shiroishi H., Sugamura K., Yaegashi N. Clinical manifestations and outcomes of parvovirus B19 infection duting pregnancy in Japan. Tohoku J. Exp. Med., 2006, vol. 209, рр. 277–283. doi: 10.1620/tjem.209.277
  8. Heegaard E., Brown K. Human parvovirus B19. Clin. Microb. Rev., 2002, vol. 15, no. 3, pp. 485–505. doi: 10.1128/CMR.15.3.485-505.2002
  9. Hourfar M.K., Mayr-Wohlfart U., Themann A., Sireis W., Seifried E., Schrezenmeier H., Schmidt M. Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion, 2011, vol. 51, no. 1, pp. 129–136. doi: 10.1111/j.1537-2995.2010.02780.x
  10. Jordan J., Tiangco B., Kiss J., Koch W. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang., 1998, vol. 75, pp. 97–102. doi: 10.1046/j.1423-0410.1998.7520097.x
  11. Lefrère J.-J., Servant-Delmas A., Candotti D., Mariotti M., Thomas I., Brossard Y., Lefrère F., Girot R., Allain J.-P., Laperche S. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood, 2005, vol. 106, no. 8, pp. 2890–2895. doi: 10.1182/blood-2005-03-1053
  12. Marano G., Vaglio S., Pupella S., Facco G., Calizzani G., Candura F., Liumbruno G.M., Grazzini G. Human parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus., 2014, vol. 13, pp. 1–13. doi: 10.2450/2014.0174-14
  13. Trimble S., Parker C.S., Grant A.M., Soucie J.M., Reyes N. Assessing emerging infectious threats to blood safety for the blood disorders community. J. Prev. Med., 2010, vol. 38, pp. 468–474. doi: 10.1016/j.amepre.2009.12.019
  14. Young N.S., Brown K.E. Mechanisms of disease: parvovirus B19. N. Engl. J. Med., 2004, vol. 350, no. 6, pp. 586–597. doi: 10.1056/NEJMra030840
  15. Yu M.Y., Alter H.J., Virata-Theimer M.L., Geng Y., Ma L., Schechterly C.A., Colvin C.A., Luban N.L. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion, 2010, vol. 50, no. 8, pp. 1712–1721. doi: 10.1111/j.1537-2995.2010.02591.x

Copyright (c) 2015 Antipova A.Y., Nikishov O.N., Khamitova I.V., Semenov A.V., Bichurina M.A., Kuzin A.A., Lavrentieva I.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies